These 33 genes include known cancer genes such as KDM6A, CDK2, and CCND1, for which CRISPR knockout show increased sensitivity in cell lines with combined SV breakpoint and gene over-expression (Fig. 8c). The gene discussed is CDK2; the disease is cancer.